Meeting
2013 Genitourinary Cancers Symposium
Overtreatment of low-risk prostate cancer in the United States: Incidence, cost, complications, and implications for the screening debate.
Authors
Ayal A. Aizer
Harvard Radiation Oncology Program, Boston, MA
Ayal A. Aizer , Xiangmei Gu , Toni K. Choueiri , Neil E. Martin , Jim C. Hu , Paul Linh Nguyen
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
General Poster Session A: Prostate Cancer
Track
Prostate Cancer
Sub Track
Prostate Cancer
Citation
J Clin Oncol 31, 2013 (suppl 6; abstr 161)
DOI
10.1200/jco.2013.31.6_suppl.161
Abstract #
161
Poster Bd #
K10
Abstract Disclosures
Similar Posters
Poster
2015 Genitourinary Cancers Symposium
Incidence, predictors, and cost implications of gastrointestinal complications following intensity-modulated radiation therapy for prostate cancer.
First Author: Monica J. Wood
Poster
2012 ASCO Annual Meeting
Proton radiotherapy for prostate cancer in the Medicare population: Patterns of care and comparison of early toxicity with IMRT.
First Author: James B. Yu
Poster
2024 ASCO Genitourinary Cancers Symposium
Pretreatment colonoscopy impact on acute gastrointestinal (GI) toxicity following curative stereotactic body radiation therapy (SBRT) for localized prostate cancer.
First Author: Jonathan W. Lischalk
Poster
2022 ASCO Genitourinary Cancers Symposium
Radiation technique and outcomes following moderately hypofractionated treatment of low risk prostate cancer: A secondary analysis of the NRG oncology RTOG 0415 randomized clinical trial.
First Author: David James Carpenter